These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 17560111

  • 1. Design, synthesis, and biological evaluation of LNA nucleosides as adenosine A3 receptor ligands.
    Ravn J, Qvortrup K, Rosenbohm C, Koch T.
    Bioorg Med Chem; 2007 Aug 15; 15(16):5440-7. PubMed ID: 17560111
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Design and synthesis of 3'-ureidoadenosine-5'-uronamides: effects of the 3'-ureido group on binding to the A3 adenosine receptor.
    Jeong LS, Kim MJ, Kim HO, Gao ZG, Kim SK, Jacobson KA, Chun MW.
    Bioorg Med Chem Lett; 2004 Oct 04; 14(19):4851-4. PubMed ID: 15341938
    [Abstract] [Full Text] [Related]

  • 6. A series of 2,4-disubstituted quinolines as a new class of allosteric enhancers of the adenosine A3 receptor.
    Heitman LH, Göblyös A, Zweemer AM, Bakker R, Mulder-Krieger T, van Veldhoven JP, de Vries H, Brussee J, Ijzerman AP.
    J Med Chem; 2009 Feb 26; 52(4):926-31. PubMed ID: 19161279
    [Abstract] [Full Text] [Related]

  • 7. Functionalized congeners of A3 adenosine receptor-selective nucleosides containing a bicyclo[3.1.0]hexane ring system.
    Tosh DK, Chinn M, Ivanov AA, Klutz AM, Gao ZG, Jacobson KA.
    J Med Chem; 2009 Dec 10; 52(23):7580-92. PubMed ID: 19499950
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. IB-MECA and cardioprotection.
    Xu Z, Jang Y, Mueller RA, Norfleet EA.
    Cardiovasc Drug Rev; 2006 Dec 10; 24(3-4):227-38. PubMed ID: 17214599
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Design, synthesis and evaluation of constrained methoxyethyl (cMOE) and constrained ethyl (cEt) nucleoside analogs.
    Seth PP, Siwkowski A, Allerson CR, Vasquez G, Lee S, Prakash TP, Kinberger G, Migawa MT, Gaus H, Bhat B, Swayze EE.
    Nucleic Acids Symp Ser (Oxf); 2008 Dec 10; (52):553-4. PubMed ID: 18776499
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptor.
    Volpini R, Dal Ben D, Lambertucci C, Taffi S, Vittori S, Klotz KN, Cristalli G.
    J Med Chem; 2007 Mar 22; 50(6):1222-30. PubMed ID: 17309246
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Orthogonal activation of the reengineered A3 adenosine receptor (neoceptor) using tailored nucleoside agonists.
    Gao ZG, Duong HT, Sonina T, Kim SK, Van Rompaey P, Van Calenbergh S, Mamedova L, Kim HO, Kim MJ, Kim AY, Liang BT, Jeong LS, Jacobson KA.
    J Med Chem; 2006 May 04; 49(9):2689-702. PubMed ID: 16640329
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.